Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “End-of-Life”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableActive Not RecruitingNCT06651645
What this trial is testing

Pre- vs Post-Pandemic Risk-adjusted Survival Rates in the US Hospitals

Who this might be right for
In-hospital MortalityNon-COVID DeathsSurge
National Institutes of Health Clinical Center (CC) 30,000,000
Not applicableStudy completedNCT04068909
What this trial is testing

ObseRvation After Acute Coronary Syndrome for deveLopment of trEatment Options

Who this might be right for
Acute Coronary Syndrome
Central State Medical Academy 1,655
Testing effectiveness (Phase 2)Active Not RecruitingNCT06502977
What this trial is testing

Study Evaluating Tarlatamab in Chinese Participants With Advanced Small Cell Lung Cancer After Two or More Prior Lines of Treatment

Who this might be right for
Extensive Stage Small Cell Lung Cancer
Amgen 32
Not applicableStudy completedNCT05908630
What this trial is testing

Accidental Hypothermia in Drowning-related OHCA

Who this might be right for
Hypothermia, AccidentalHypothermia Due to Cold EnvironmentDrowning+1 more
Prehospital Center, Region Zealand 119
Not applicableStudy completedNCT03456921
What this trial is testing

Using an End-of-life Conversation Game to Engage Underserved Communities in Advance Care Planning

Who this might be right for
Advance Care PlanningVulnerable PopulationsAdvance Directives+1 more
Milton S. Hershey Medical Center 1,122
Testing effectiveness (Phase 2)Active Not RecruitingNCT06483334
What this trial is testing

Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Plus Enfortumab Vedotin (EV) With and Without Pembrolizumab in Advanced Urothelial Carcinoma (MK-3475-04C/KEYMAKER-U04)

Who this might be right for
Metastatic Urothelial CarcinomaLocally Advanced Urothelial Carcinoma
Merck Sharp & Dohme LLC 38
Not applicableStudy completedNCT07505706
What this trial is testing

Patient Journey in Palliative Care Within the NOVO Hospital Group.

Who this might be right for
Palliative CareEnd of Life CareTerminal Care
Hôpital NOVO 286
Not applicableStudy completedNCT04371471
What this trial is testing

Pandemic Triage Score in Patients With Known or Suspected Severe Acute Respiratory Syndrome (SARS) CoronaVirus (CoV) 2 Infection

Who this might be right for
SARS-CoV-2 Acute Respiratory DiseaseCovid19
Groupe Hospitalier de la Rochelle Ré Aunis 91
Not applicableStudy completedNCT02955563
What this trial is testing

CSDM: A Trial to Improve Communication and Shared Decision Making Using a Web-Based Tool

Who this might be right for
Intervention ComplianceUsabilityAcceptability
University of Pittsburgh 52
Testing effectiveness (Phase 2)Study completedNCT05535569
What this trial is testing

Phase Ib/II Study to Evaluate the Safety and Efficacy of Nivolumab in Combination With Paclitaxel in Epstein-Barr Virus(EBV)-Related, or Microsatellite Instability-High (MSI-H), or Programmed Cell Death Ligand 1 (PD-L1) Positive Advanced Gastric Cancer

Who this might be right for
Recurrent/Metastatic Gastric Cancer
Yonsei University 50
Not applicableUnknownNCT03642405
What this trial is testing

Drug-induced Repolarization ECG Changes

Who this might be right for
Long QT SyndromeADHDDepression+17 more
Copenhagen University Hospital at Herlev 150
Large-scale testing (Phase 3)Looking for participantsNCT06345729
What this trial is testing

Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004)

Who this might be right for
Non-small Cell Lung Cancer
Merck Sharp & Dohme LLC 600
Large-scale testing (Phase 3)Not Yet RecruitingNCT07818070
What this trial is testing

A Trial of ONO-4578 Versus Placebo in Combination With Nivolumab and Chemotherapy in Participants With Gastric Cancer, Esophagogastric Junction Cancer, or Esophageal Adenocarcinoma

Who this might be right for
Gastric CancerEsophagogastric Junction CancerEsophageal Adenocarcinoma
Ono Pharmaceutical Co., Ltd. 600
Early research (Phase 1)Study completedNCT02350673
What this trial is testing

Intravenous (IV) Cergutuzumab Amunaleukin and Atezolizumab in Combination in Participants With Locally Advanced and/or Metastatic Solid Tumors

Who this might be right for
Solid Tumors
Hoffmann-La Roche 70
Not applicableStudy completedNCT00616473
What this trial is testing

Quality End-of-Life Care in Nursing Homes

Who this might be right for
Quality of End-of-life Care in Nursing Homes
University of Nebraska 7,169
Testing effectiveness (Phase 2)Active Not RecruitingNCT06504394
What this trial is testing

Evaluate the Safety and Efficacy of Pembrolizumab (MK-3475) Coformulated With Berahyaluronidase Alfa (MK-3475A) in Participants With Relapsed or Refractory Classical Hodgkin Lymphoma (rrcHL) or Relapsed or Refractory Primary Mediastinal Large B-cell Lymphoma (rrPMBCL)(MK-3475A-F65)

Who this might be right for
Classical Hodgkin Lymphoma RecurrentClassical Hodgkin Lymphoma RefractoryPrimary Mediastinal Large B-cell Lymphoma Recurrent+1 more
Merck Sharp & Dohme LLC
Not applicableStudy completedNCT04595656
What this trial is testing

Defining Causes of Deaths in South and Southeast Asia

Who this might be right for
Cause of MortalityCause of Neonatal DeathCause of Child Death+2 more
University of Oxford 3,413
Large-scale testing (Phase 3)Active Not RecruitingNCT04700124
What this trial is testing

Perioperative Enfortumab Vedotin (EV) Plus Pembrolizumab (MK-3475) Versus Neoadjuvant Chemotherapy for Cisplatin-Eligible Muscle Invasive Bladder Cancer (MIBC) (MK-3475-B15/ KEYNOTE-B15 / EV-304)

Who this might be right for
Bladder Cancer
Merck Sharp & Dohme LLC 808
Not applicableUnknownNCT02601066
What this trial is testing

Cardiac Arrhythmias and Sudden Death in Patients Affected With Laminopathies

Who this might be right for
Cardiomyopathy Associated With Myopathy and Sudden Death
Hospital Sant Joan de Deu 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT06041802
What this trial is testing

Pembrolizumab (+) Berahyaluronidase Alfa (MK-3475A) (Pembrolizumab Formulated With Berahyaluronidase Alfa (MK-5180)) in Japanese Participants With Recurrent or Metastatic Cutaneous Squamous Cell Carcinoma (R/M cSCC) or Locally Advanced (LA) Unresectable cSCC (MK-3475A-E39)

Who this might be right for
Squamous Cell Carcinoma
Merck Sharp & Dohme LLC 19
Next Page
66